Reactions Weekly

, Volume 1709, Issue 1, pp 238–238 | Cite as

Sucroferric oxyhydroxide

Discolouration of faeces: case report
Case report


  1. Griveas I, et al. Sucroferric oxyhydroxide: A novel phosphate binder for the management of mineral bone disease in dialysis patients with "pleiotropic" effects. Nephrology Dialysis Transplantation 33 (Suppl. 1): i253 abstr. FP627B, May 2018. Available from: URL: [abstract] -Greece

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations